01.06.2013
A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
Erschienen in: The journal of nutrition, health & aging | Ausgabe 6/2013
Einloggen, um Zugang zu erhalten